Merck Tbk. vs Gaya Abadi Sempurna Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Gaya Abadi Sempurna Tbk. trades at Rp59 (market cap 145.34B, 10.69M 24h volume). The key difference: Merck Tbk. is far larger — about 11.7× Gaya Abadi Sempurna Tbk.'s market cap, and Gaya Abadi Sempurna Tbk. is more actively traded (10.69M versus 37.6K). Which is the better fit depends on your goals.
| MERK | SLIS | |
|---|---|---|
Market Cap | 1.7T | 145.34B |
Volume | 37.6K | 10.69M |
Lot | 376 | 106.93K |
Turnover | 144.47M | 638.58M |
Average Price | 3,842.23 | 59.72 |
Value | 144.47M | 638.58M |
Indicative Equilibrium Price | 3,840 | 59 |
Indicative Equilibrium Volume | 7 | 2.71K |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Gaya Abadi Sempurna Tbk. (The Company) was established based on Notarial Deed Soekaimi S.H., No. 155 dated September 26, 1996, Notary in Jakarta. The company have began its commercial operations since 1996.The Company’s holding entity and ultimate holding entity as of April 30, 2019 is PT Selis Investama Indonesia
Read more on SLIS →